NAME Prof. Maria Kavallaris
CANCER TYPE Neuroblastoma
INSTITUTION University of New South Wales
STATE New South Wales
GRANT TYPE $80,000

"Advanced stage neuroblastoma is a highly aggressive childhood cancer and 5‐year survival rates are less than 35%. Due to toxic effects of therapy, survivors have life‐long health issues. Using state‐of‐the‐art nanotechnology we are delivering chemotherapy to cancers cells to provide effective and less toxic therapies and increase patient survival."

Professor Maria Kavallaris, researcher of University of New South Wales.